Current Management of Primary Pulmonary Hypertension
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (13) , 1945-1956
- https://doi.org/10.2165/00003495-200161130-00005
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Short-term hemodynamic effect of a new oral PGI2 analogue, Beraprost, in primary and secondary pulmonary hypertensionThe American Journal of Cardiology, 1996
- Pharmacodynamic profile of prostacyclinThe American Journal of Cardiology, 1995
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- Atrial septostomy as palliative therapy for refractory primary pulmonary hypertensionThe American Journal of Cardiology, 1983
- Captopril in primary pulmonary hypertension.Circulation, 1983
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.Thorax, 1980
- Echocardiographic features of primary pulmonary hypertensionThe American Journal of Cardiology, 1974